References
- 1. Cortese A, Vegezzi E, Lozza A, Alfonsi E, Montini A, Moglia A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017;88(5):457-8.10.1136/jnnp-2016-315262
- 2. Simmons Z, Blaivas M, Aguilera AJ, Feldman EL, Bromberg MB, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci. 1993;120(1):60-3.10.1016/0022-510X(93)90025-T
- 3. Kollmer J, Weiler M, Purrucker J, Hegenbart U, Schönland S, Kimmich C, et al. MRNeurography of the sural nerve in patients with hereditary amyloidosis. Orphanet Journal of Rare Diseases. 2015;10(1):P40.10.1186/1750-1172-10-S1-P40
- 4. Jercan A, Ene A, Jurcut R, Draghici M, Badelita S, Dragomir M, et al. Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet Journal of Rare Diseases. 2020;15(1):34.10.1186/s13023-020-1309-9699331332000831
- 5. Alport AR, Sander HW. Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap Minn). 2012;18(1):13-38.10.1212/01.CON.0000411546.13207.b1
- 6. Nehashi T, Oikawa M, Amami K, Kanno Y, Yokokawa T, Misaka T, et al. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. Int Heart J. 2019;60(6):1441-3.10.1536/ihj.19-13431666456
- 7. Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferović PM, et al. Treatment of cardiac transthyretin amyloidosis: an update. European Heart Journal. 2019;40(45):3699-706.10.1093/eurheartj/ehz29831111153
- 8. Coelho T, Merlini G, Bulawa CE, Fleming JA, Judge DP, Kelly JW, et al. Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Neurology and Therapy. 2016;5(1):1-25.10.1007/s40120-016-0040-x491913026894299
- 9. Mazzeo A, Russo M, Di Bella G, Minutoli F, Stancanelli C, Gentile L, et al. Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area. J Neuromuscul Dis. 2015;2(s2):S39-S48.10.3233/JND-150091527142127858761